SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

TScan Therapeutics Q3 Revenue Drops After Amgen Collaboration Ends

TScan Therapeutics reported lower Q3 revenue following the end of its collaboration with Amgen.

TCRX

Related stories